85
Fashion Jobs
JO MALONE LONDON
Education Manager, Jml/lm
Permanent · HO CHI MINH CITY
L'OREAL GROUP
Senior HR Operations Executive/ Assistant Manager
Permanent · HO CHI MINH CITY
ADIDAS
Key Account Manager (Franchise)
Permanent · HO CHI MINH CITY
ADIDAS
Senior Manager, Commercial, Adigolf, Vietnam 1
Permanent · HO CHI MINH CITY
ADIDAS
Key Account Manager 1 (Franchise)
Permanent · HO CHI MINH CITY
COLUMBIA
lo Costing & Engineering Manager
Permanent · HO CHI MINH CITY
L'OREAL GROUP
Category Manager - Cpd
Permanent · HO CHI MINH CITY
L'OREAL GROUP
Business Planning Manager - Cpd
Permanent · HO CHI MINH CITY
ADIDAS
Senior Manager Product Creation (Sportwear)
Permanent · HO CHI MINH CITY
L'OREAL GROUP
Product Manager - Shu Uemura
Permanent · HO CHI MINH CITY
ADIDAS
Manager, Quality Product Integrity
Permanent · HO CHI MINH CITY
TAPESTRY
Manager, Manufacturing Engineer
Permanent · HO CHI MINH CITY
SPECIALIZED
Painting Quality Engineer - Bình Dương, Vietnam
Permanent ·
ON RUNNING
Social Compliance Specialist - Hcm Based
Permanent · HO CHI MINH CITY
ADIDAS
Senior Manager, Sourcing Operations
Permanent · HO CHI MINH CITY
WILLIAMS SONOMA
Wood Sustainability Specialist - (Global)
Permanent · THUẬN AN
PUMA
Manager Quality Apparel & Accessories
Permanent · HO CHI MINH CITY
PUMA
Senior Executive, Finance
Permanent · HO CHI MINH CITY
PUMA
Head of Quality Footwear
Permanent · HO CHI MINH CITY
PUMA
Quality Engineer Cobra
Permanent · HO CHI MINH CITY
PUMA
Key Account Manager, Marketplace E-Com
Permanent · HO CHI MINH CITY
ON RUNNING
Head of Footwear Sourcing
Permanent · HO CHI MINH CITY
By
Reuters
Published
Jul 18, 2018
Reading time
2 minutes
Download
Download the article
Print
Text size

J&J beats quarterly expectations, shares jump

By
Reuters
Published
Jul 18, 2018

Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent, and its shares rose more than 4 percent.

Instagram @johnsonsbaby


The healthcare conglomerate also expressed confidence that last week’s finding by a Missouri jury that J&J’s talc-based products caused cancer, and an order to pay a record $4.69 billion (3.56 billion pounds) to defendants, would not stand.

“We are confident that there are multiple grounds for reversal of this jury verdict and that, ultimately, the case will be reversed,” Chief Executive Alex Gorsky said on a call with analysts. He said the products do not contain asbestos or cause ovarian cancer.

Morningstar analyst Damien Conover said he expects J&J to be aggressive in fighting these lawsuits, “and the final related payments will not cause a major impact to its valuation.”

J&J shares were up 3.2 percent at $128.70 after earlier climbing as much as 4.6 percent - the biggest one-day percentage gain in over two years.

Gorsky acknowledged that sales growth in the consumer products division and some segments of medical devices were disappointing. New drugs and those in development “position us well to outgrow the market for many years to come,” he said.

Net earnings rose to $3.95 billion, or $1.45 per share, from $3.83 billion, or $1.40 per share, a year earlier.

Total sales rose 10.6 percent to $20.83 billion, topping analysts’ estimates of $20.39 billion.

J&J lowered its full-year sales forecast to $80.5 billion to $81.3 billion from $81.0 billion to $81.8 billion, citing a strengthening dollar for the trim.

J&J narrowed its 2018 adjusted earnings forecast, raising the midpoint by 2 cents. It now expects $8.07 to $8.17 per share, up from its prior view of $8.00 to $8.20.

Excluding items, the company reported a profit of $2.10 per share, beating analysts’ average estimate by 3 cents.

© Thomson Reuters 2024 All rights reserved.